Reliable internet connection an integral part of movement to DCTs.
A shift towards more decentralized clinical trials (DCTs) calls for a new look at how to set up and maintain strong WiFi networks in healthcare. It’s these networks that make decentralized trials possible. For that reason, they must be optimized and reliable at all times.
While the participants in DCTs are dependent on their home WiFi networks, the researchers and other medical professionals involved in the trials are more likely to be located in one or more central locations, either office buildings or mobile sites. The WiFi networks in these locations must support all trial needs. Any issues, such as network downtime, can result in expensive delays and frustrated users.
Follow these steps to establish a strong WiFi network in a new site:
If working in a building that already has a WiFi network, review network performance to be sure it will meet researchers’ needs. If the building layout has changed in any way, or if there has been a significant change in the number or type of WiFi devices in the building, it might be necessary to perform another site survey. This will make sure any new interference issues are identified right away.
Finally, just as when establishing a new network, be sure security is up-to-par and utilize three SSIDs. Make sure that all employees use the most secure network to communicate with patients and store data.
WiFi network ecosystems are dynamic. They change constantly as devices connect and disconnect, as different apps are utilized, as upgrades are pushed out, and as infrastructure undergoes regular wear and tear. The only way to maintain a reliably strong network is to:
WiFi automation solutions automate WiFi network optimization. They change optimization from a manual, reactive process, to one that is automatic and proactive. These solutions:
By using WiFi automation, IT professionals responsible for medical WiFi networks automatically have access to the analytics they need to ensure networks are reliable, optimized, and secure. With this support, DCTs can run without medical researchers worrying about poor service affecting telehealth appointments, data retrieval, data storage, or any other trial element dependent on the WiFi network.
Roger Sands, CEO and Founder, Wyebot
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.